TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain M Q1 2026 Earnings EPS Beats Estimates Amid Operational Adjustments HTH Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline BIOA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage GLDD Q4 2025 Earnings Strong EPS Beat Driven by Operational Efficiency NTRSO Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment